Shoji Nagao

17PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Reproductive medicine not elsewhere classifiedPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 03, 2026
A Biologically Dominant Trophoblastic Component Guiding Neoadjuvant EMA/CO in Endometrial Carcinoma: A Clinical Case Report.

|Mar 27, 2026
Incidence of pelvic fractures after definitive radiotherapy for cervical cancer: A retrospective multicenter cohort study (The IPFAR study).

Shinsuke Shirakawa, Shoji Nagao, Kotaro Yoshio

|Mar 14, 2026
The New Era of Intraperitoneal Carboplatin in Ovarian Cancer: From Biological Rationale to Clinical Implementation.

Shoji Nagao, Atsushi Fujikawa, Yui Tanaka

|Jan 13, 2026
Fertility-sparing surgery with neoadjuvant chemotherapy in early and locally advanced cervical cancer: A clinical protocol.

Momoko Tanioka, Shoji Nagao, Naoyuki Ida

|Aug 14, 2025
The Concept of "Platinum Sensitivity" in Endometrial Cancer.

Shoji Nagao, Atsushi Fujikawa, Ryoko Imatani

|Mar 03, 2025
Epithelioid trophoblastic tumor diagnosed during a thorough examination of recurrent implantation failure: A case report.

Yasuhiko Kamada, Junko Haraga, Naoyuki Ida

Pageof 3

Frequent Collaborators

2 joint publications

Kazuhiro Takehara

2 joint publications

Takashi Matsumoto

2 joint publications

Junzo Hamanishi

2 joint publications

Kosei Hasegawa